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Background: Patients with oncological diseases often have mental disorders in the form of  comorbidity. The 
aim of  this study was to research the association of  cancer with the presence of  symptoms of  depression and 
anxiety in primary health care patients. 
Methods: This prospective observational study done in 2020 included adult users of  health care at the Health 
Center Trstenik, Central Serbia, aged 19 and over, both sexes, with a diagnosis of  oncological disease. A 
research instrument to assess depressive symptoms is used PHQ-9 (The Patient Health Questionnaire) 
questionnaire, derived from PRIME MD- and (The Primary Care Evaluation of  Mental Disorders), and the 
Beck Anxiety Scale (BAI) to register the presence of  certain anxiety symptoms.  
Results: The largest percentage of  patients had symptoms of  mild (27.2%) or moderate depression (22%), 
while 18% reported symptoms of  major depression. The level of  depression was higher in older subjects, in 
the presence of  chronic diseases with greater limitations of  activity and the presence of  difficulties in 
performing daily activities, with a more pronounced effect of  pain on activity, the presence of  stress. All 
subjects were characterized as persons with severe anxiety (score 26-63). The level of  anxiety was higher in 
older respondents, in the presence of  long-term illness, with greater limitations of  activities and difficulties in 
performing daily activities, with a more pronounced influence of  pain on performing activities and the 
influence of  the media. 
Conclusion: Caring for the mental health of  cancer patients must occupy a significant part of  each country's 
national health policy. 
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Diagnosis of malignant disease and the process 
of modern and very complex treatment, can 
cause not only somatic problems among patients 
but very intense emotional reactions, with signifi-
cant psychological consequences. The results of 
modern scientific research indicate that patients 
with oncological diseases often have mental dis-
orders (in the form of comorbidity), with depres-
sive and anxiety symptoms being the most com-
mon (1- 8). Mental health disorders are directly 
related to the level of disability, disease progres-
sion, the presence of pain and accompanying side 
effects of certain chemotherapeutic drugs, sad-
ness due to current and expected losses, fear of 
diagnostic and therapeutic procedures, and fear 
of death (9). Although the relationships between 
oncological diseases and mental disorders can 
vary (depending on the course, stage, and prog-
nosis of the disease itself), the fact is that onco-
logical diseases are more strongly associated with 
depression and anxiety than any other disease. 
Besides, mental disorders can be developed from 
almost all types of oncological diseases and their 
existence can affect and cause the poorer adher-
ence to prescribed therapeutic treatments, wors-
ening the quality of life and increased mortality 
(10). Data from the literature shows the fact that 
patients with malignant diseases with mental dis-
orders usually do not receive adequate treatment, 
despite the existence of effective psycho-
oncological interventions, especially for common 
problems such as depression and anxiety (11). 
Mental disorders among these patients are often 
unrecognized by healthcare professionals. These 
disorders are usually masked by the clinical pic-
ture of underlying disease symptoms or treatment 
effects such as fatigue, loss of appetite, sleep 
problems, nausea, vomiting, and may negatively 
affect the cooperation and treatment acceptance, 
functional and cognitive patient ability, quality of 
life, recovery, and survival (11).  
The aim of this study was to research the associa-
tion of cancer with the presence of symptoms of 
depression and anxiety in primary health care pa-
tients. The relationship between depression and 
anxiety among cancer patients has not been fully 
investigated in The Republic of Serbia, which 
contributes to the relevance of this research. 
 
Materials and Methods 
 
Study Design and Sample 
The research was conducted in the form of a 
prospective observational study was done in 2020 
which included users of health care at the Health 
Center Trstenik, Central Serbia, aged 19 and 
over, both sexes, with a diagnosis of oncological 
disease (inspection of medical documentation - 
health card). 
Before the start of the study, patients were intro-
duced to the purpose and procedure of the study 
and gave informed consent to participate in this 
study. The protocols of this research were ap-
proved by the Ethics Committee of the Health 
Center Trstenik, Central Serbia. 
Inclusion criteria for participation in the study 
were patients with diagnosed oncological diseases 
who signed informed consent for participation in 
the study, while exclusion criteria were patients 
under 19 years of age, the presence of psychiatric 
illness, the presence of acute infectious (infec-
tious) disease, the presence of chronic infectious 
diseases, pregnant women and patients who did 




Besides the general questionnaire on demograph-
ic and socio-economic characteristics (European 
Health Survey Questionnaire - Second Wave) 
(12), as a research instrument to assess depressive 
symptoms is used PHQ-9 (The Patient Health 
Questionnaire) questionnaire, derived from PRIME 
MD- and (The Primary Care Evaluation of Men-
tal Disorders). 
PHQ-9 is a shorter form questionnaire related to 
the following mental problems: decreased interest 
or satisfaction in performing activities; discour-
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agement, depression, hopelessness; sleep prob-
lems (problem falling asleep, sleeping continu-
ously, or sleeping too much); feeling tired or lack-
ing in energy; decreased or increased appetite; 
bad opinion of oneself, feeling of failure, disap-
pointment in oneself or one's family (feeling of 
worthlessness or excessive or inadequate feeling 
of guilt); difficulty concentrating on activities 
such as reading newspapers or watching televi-
sion (reduced ability to think, concentrate or in-
decision - assessed subjectively or by others); 
slow movement or speech or vice versa, psycho-
motor restlessness and polykinesia (noticed by 
others, not just as a subjective feeling); suicidal 
thoughts. The scale consists of 9 questions with 
possible answers "no problem" (which is scored 
with zero points) or "a few days, sometimes" 
(which is scored with 1 point), or "more than 7 
days'' (which is scored with 2 points) points), or 
“almost every day” (which is scored with 3 
points). Adding points for each answer gives a 
total score ranging from 0 to 27. Score values 
from 0 to 4 indicate the absence of depressive 
symptoms, a score from 5 to 9 indicates mild de-
pressive symptoms (subsyndromal depression), 
and a score of 10 or more indicates a high proba-
bility of the existence of a depressive episode, 
which is further qualified as moderate (score 
from 10 to 14), moderately severe (score from 15 
to 19) and severe depression (score 20 and more). 
Based on the PHQ-9 score, subjects were classi-
fied into one of the following categories: no de-
pressive symptoms, mild depressive symptoms 
(subsyndromal depression), and depressive epi-
sode (moderate, moderate, and severe depres-
sion) (13). 
The Beck Anxiety Scale (BAI) which can be used 
for both clinical and research purposes, in this 
study was not used to diagnose anxiety disorders 
but to register the presence of certain anxiety 
symptoms. Questions referred to the presence of 
certain symptoms of anxiety (e.g. fear of the 
worst, nervousness, inability to relax, fear or 
dread, shivering, feeling out of control, etc.). 
Each question has a range of four possible an-
swers among which respondents choose one (0- 
no at all, 1- mild "didn't bother me much", 2- 
moderate "it was occasionally very uncomforta-
ble" and 3-serious "it was almost unbearable"). 
The scale is graded that the first answer carries 0 
and the fourth 3 points. The range of possible 
points on the scale ranges from 0 to 63. Based on 
the scores obtained on the scale, respondents 
were classified into one of four categories: 0-7 
those with a minimum level of anxiety, 8-15 
those with mild anxiety, 16-25 those with moder-
ate anxiety, and 26-63 those with severe anxiety 
(14). 
Social support score (Oslo-3 Social Support 
Scale) was formed on the basis of three questions 
from the question-naire: “How many people are 
so close to you that you can count on them when 
you have serious personal problems?” , “How 
many  people  are  really  interested  in  you,  in  
what  you  are  doing,  or  in  what  is  going  on  
in  your  life?”  , “How easy is for you to get 
practical help from neighbors if you have a need 
for it?” The number of points ranges from 1 to 5. 
After collecting points, the scores of social sup-
port were formed: a strong social support (12-14 
points), moderate (9-11 points) and bad (3-8 
points), (15).  
Insight into the medical documentation (health 
card) collected data on the presence/absence of 
oncological diseases as well as the presence of 
comorbidities. The dependent variable in the 
study was the presence of symptoms of depres-
sion and anxiety in primary care cancer patients. 
Independent variables in the research were: de-
mographic characteristics: gender, age, marital 
status, family structure, type of settlement; socio-
economic characteristics (occupation, education, 
material status); health self-assessment; health 
condition (presence of another chronic non-
communicable disease); ability to perform daily 
activities; use of primary and hospital health care, 
unmet health care needs; determinants of health 
(smoking, alcohol use, physical activity, hygiene 




Descriptive statistics methods were used to pre-
sent the data: tabulation and graphical representa-
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tion. The chi-square (χ2) test is used to compare 
differences in the frequency of categorical varia-
bles. The relationships between the dependent 
variable (presence/absence of depression and 
anxiety) and the set of independent variables 
were examined by univariate and multivariate lo-
gistic regression. The risk was assessed using the 
size of the OR (odds ratio), with a 95% confi-
dence interval. All results where the probability is 
less than 5% (P <0.05) were considered statisti-
cally significant. All statistical calculations were 
done using the commercial, standard software 





The study included 250 patients aged 19 years 
and older, with a diagnosis of cancer: 174 females 
(69.6%) and 76 males (30.4%). Slightly more pa-
tients were from rural areas 52.4%, in the marital 
community 68.4%, with secondary education are 
40.8% (Table 1). The most common cancers 
were breast cancer (28.3%), bronchial and lung 
cancer (7.2%), and prostate cancer (5.6%), (Table 
2). When it comes to the stage of the disease, 
(65.7%) they were in the first stage of the disease, 
(33.1%) in the second, and (1.2%) in the third.
 
Table 1: Sociodemographic characteristics of  cancer patients 
 
Variables N° (%) 
Gender Male 76 (30.4) 
Female 174 (69.6) 
Environment 
 
Rural 131 (52.4) 




Unmarried 5 (2) 
Marriage 171 (68.4) 
Widow(er) 50 (19.9) 






Without school 8 (3.2) 
Primary school 91 (36.4) 
Secondary school 102 (42.4) 
Higher scool 17 (6.8) 
College/undergraduate studies 28 (11.2) 
Employment  
  
Employed 115 (45.8) 
Self-employed 3 (1.2) 





Very good 7 (2.8) 
Good 1 (0.4) 
Average  77 (30.8) 
Bad 161 (64.4) 
Very bad 4 (1.6) 
The presence of physical pain 





Without pain - 
Very weak 31 (12.4) 
Weak 33 (13.2) 
Moderate 124 (49.6) 
Strong 61 (24.4) 
Very strong 1 (0.4) 
 
Influence of pain on activities 
Not at all 6 (2.4) 
Little 48 (19.2) 
Moderate 118 (47.2) 
Much 63 (25.2) 
Very much 15 (6) 
Social support  
  
Strong - 
Moderate 26 (10.4) 
Bad 224 (89.6) 
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Table 2: The incidence of individual types of cancer in the study population 
 
Cancer identifi-
cation on the 
chart 
ICD mark Localization Percentage share 
in the study pop-
ulation 
1 C00 Lips 0.8 
2 C10 Oropharynx 2.0 
3 C17 Small intestine 1.6 
4 C18 Colon 4.4 
5 C19 Sigma and rectum 3.6 
6 C20 Rectum 3.6 
7 C21 Anus 5.2 
8 C23 Gallbladder 1.2 
9 C25.9 Pancreas 1.6 
10 C30 Nasal cavity 0.4 
11 C32 Larynx 2.4 
12 C33 Trachea 0.8 
13 C34 Bronchus and lungs 7.2 
14 C43 Melanoma 3.2 
15 C44 Skin 1.6 
16 C45 Pleural mesothelioma 0.8 
17 C50 Breast 28.3 
18 C51 Vulva 0.8 
19 C52 Vagina 1.2 
20 C53.1 Exocervix 5.2 
21 C54.3 Uterus 1.2 
22 C56 Ovary 2.4 
23 C61 Prostate 5.6 
24 C62 Testicle 0.4 
25 C64 Kidney 3.6 
26 C67 Bladder 3.2 
27 C70 Meninges 0.4 
28 C73 Thyroid gland 2.0 
29 C77 Lymph nodes 4.0 
30 C81.9 Hodgkin 1.2 
31 C90 Multiple myeloma 3.6 
 
Prevalence and Factors Associated with De-
pression 
The mean value of the depression score at the 
level of the entire study population was 11.6 ± 
6.9 (range 0-25). The largest percentage of pa-
tients included in the study had symptoms of 
mild depression (27.2%) or moderate depression 
(22%), while 18% of the study population report-
ed symptoms of major depression. There was a 
significant difference in PHQ-9 values among 
patients with different types of cancer (One-Way 
ANOVA, df (30) = 3,317, P <0.001). The highest 
mean PHQ-9 scores were found in patients with 
lymphoma (23.0), meningioma (22.0), and pan-
creatic cancer (20.8) (Table 3). The highest 
average values depression were recorded in 
patients in the third stage of the disease (21.5 ± 
4.9), while the values were lower in those in the 
second (12.7 ± 6.7) and the first stage of the 
disease (10.9 ± 6.9). 
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Table 3: Display of PHQ-9 score values in patients with different cancers 
 
ICD mark N° PHQ-9 (Ȳ) SD Min-Max 
C00 2 8.5 0.71 8.0‒9.0 
C10 5 12.0 4.12 7.0‒15.0 
C17 4 13.0 5.03 8.0‒20.0 
C18 11 14.7 6.26 3.0‒22.0 
C19 9 9.4 8.25 0.0‒19.0 
C20 9 9.3 3.32 4.0‒15.0 
C21 13 12.2 9.32 5.0‒25.0 
C23 3 16.3 1.53 15.0‒18.0 
C25.9 4 20.8 6.5 11.0‒24.0 
C30 1 4.0 ‒ ‒ 
C32 6 10.8 6.85 2.0‒16.0 
C33 2 0 0 0.0 
C34 18 17.0 5.07 9.0‒25.0 
C43 8 3.8 3.28 0.0‒8.0 
C44 4 8.2 4.5 6.0‒15.0 
C45 2 13.0 2.83 11.0‒15.0 
C50 71 9.5 5.93 0.0‒25.0 
C51 2 2.5 0.71 2.0‒3.0 
C52 3 5.0 5.57 0.0‒11.0 
C53.1 13 12.4 7.14 5.0‒23.0 
C54.3 3 8.7 2.89 7.0‒12.0 
C56 6 18.0 3.29 13.0‒21.0 
C61 14 12.6 6.55 2.0‒22.0 
C62 1 12.0 ‒ ‒ 
C64 9 11.6 8.37 2.0‒23.0 
C67 8 17.6 4.95 13.0‒23.0 
C70 1 22.0 ‒ ‒ 
C73 5 7.0 6.71 0.0‒15.0 
C77 1 23.0 ‒ ‒ 
C81.9 3 16.0 8.66 6.0‒21.0 
C90 9 15.6 6.15 8.0‒22.0 
 
Regression analysis showed a statistically signifi-
cant impact of the following variables on the lev-
el of depression: lower level of education, higher 
absence from work, use of antihypertensives, less 
need for help with activities, less use of ambu-
lances, less social support, and rural environment. 
The level of depression was higher in older sub-
jects, in the presence of chronic diseas-
es/conditions (comorbidities), with greater limi-
tations of activity, and the presence of difficulties 
in performing daily activities, with a more pro-
nounced effect of pain on activity, the presence 
of vision difficulties, poor oral hygiene and ten-
sion/stress (Table 4).  
 
Prevalence and Factors Associated with Anx-
iety 
The mean value of the anxiety score in the study 
population was 45.4 ± 9.5 (range 27-63). All sub-
jects in the study were characterized as persons 
with severe anxiety (score 26-63). 
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Statistical analysis revealed a significant difference 
in the severity of anxiety among patients with 
different types of cancer (One-Way ANOVA, df 
(30) = 3,197, P <0,001). The highest mean Beck 
scores were found in patients with meningioma 
(63.0), pancreatic cancer (58.2), and lymphoma 
(56.0), (Table 5). 
 
The highest average values anxiety were recorded 
in patients in the third stage of the disease (53.0 
± 14.1), while the values were lower in those in 
the second (48.1 ± 8.9) and the first stage of the 
disease (44.01 ± 9.4).  
Regression analysis showed a statistically signifi-
cant impact of the following variables on the de-
gree of anxiety: lower level of education, less 
need for help with activities, less use of home 
care, less activity, and social support. The level of 
anxiety is higher in older respondents, in the 
presence of long-term illness, with greater limita-
tions of activities and difficulties in performing 
daily activities, with a more pronounced influence 
of pain on performing activities and the influence 




Depressive and anxiety symptoms often appear 
in the form of comorbidity among patients with 
oncological diseases. Most cancer survivors ad-
just well to life after being diagnosed with cancer, 
but some experience permanent negative moods 
ranging from common feelings of vulnerability, 
sadness, and fear to a disability, depression, anxi-
ety, trauma, panic, and existential crisis that dis-
rupt normal functioning in daily activities and 











95% CI for Exp (B) 
(lower‒upper) 
 
Odds ratio p 
Age 1.9‒25.8 10.6 0.045 
Gender  0.3-0.4 0.35 0.961 
Education 0.5‒1.3 0.92 <0.001 
Environment  0.3‒9.2 4.72 0.038 
Business hours 0.9‒7.6 4.27 0.012 
Absence from the job 2.6‒8.7 5.68 <0.001 
Activity restriction 2.9‒6.2 4.62 <0.001 
Health in general 0.7‒4.2 2.43 0.006 
Chronic diseases 0.4‒1.8 1.14 0.002 
Hypertension  1.1‒2.7 1.91 <0.001 
Use of antihypertensives 0.4‒2.1 1.27 0.002 
Vision difficulties 0.3‒2.4 1.37 0.013 
Teeth condition 0.3‒2.3 1.03 0.043 
Difficulties in performing daily activities 0.2‒2.2 1.03 0.042 
Influence of the pain on activities performance  1.6‒3.1 2.30 <0.001 
The need for additional help with activities 0.9‒4.2 2.56 0.002 
Presence of tension/stress 0.6‒3.7 1.57 0.008 
Unmet health care needs 1.1‒3.7 2.14 0.001 
Using emergency help 5.3‒10.4 7.89 <0.001 
Social support 0.2‒2.4 1.42 0.036 
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Table 5: Beck score values in patients with different cancers 
 
ICD mark N° Beck score 
(Ȳ) 
SD Min-Max 
C00 2 40.0 5.65 36.0‒44.0 
C10 5 42.4 0.89 41.0‒43.0 
C17 4 48.0 8.98 37.0‒59.0 
C18 11 54.0 8.79 34.0‒62.0 
C19 9 46.2 10.34 33.0‒56.0 
C20 9 44.6 7.60 32.0‒52.0 
C21 13 45.8 13.77 32.0‒63.0 
 C23 3 49.5 2.12 48.0‒51.0 
C25.9 4 58.2 9.50 44.0‒63.0 
C30 1 38.0 ‒ ‒ 
C32 6 39.8 7.86 30.0‒46.0 
C33 2 34.0 0.0 ‒ 
C34 18 50.8 7.67 40.0‒63.0 
C43 8 32.2 4.03 28.0‒39.0 
C44 4 40.2 7.41 34.0‒51.0 
C45 2 51.5 7.78 46.0‒57.0 
C50 71 42.5 7.69 32.0‒63.0 
C51 2 32.0 7.07 27.0‒37.0 
C52 3 44.3 7.51 40.0‒53.0 
C53.1 13 47.7 9.01 37.0‒62.0 
C54.3 3 41.7 2.52 39.0‒44.0 
C56 6 54.8 5.42 44.0‒58.0 
C61 14 46.1 8.92 28.0‒62.0 
C62 1 44.0 ‒ ‒ 
C64 9 44.3 8.19 36.0‒63.0 
C67 8 52.4 8.81 38.0‒63.0 
C70 1 63.0 ‒ ‒ 
C73 5 43.6 9.50 37.0‒60.0 
C77 1 56.0 ‒ ‒ 
C81.9 3 51.3 15.01 34.0‒60.0 
C90 9 47.1 8.36 37.0‒56.0 
 
 
Some studies indicate an increased level of anxie-
ty and depression even years after diagnosis, 
which is most often caused by fear of recurrence 
and disease progression (18, 19). 
A study examining anxiety and depression in 
adult cancer survivors and related factors found 
that 40% of cancer survivors reported moderate 
to high anxiety, and approximately 20% reported 
moderate to high depression. Higher anxiety was 
significantly associated with female gender, 
younger age, lower social support, lower physical 
health, and poorer family functioning (20). Being 
unemployed, receiving less social support, not 
being treated, a shorter time than diagnosis, 
poorer physical health, and poorer family func-
tioning were significantly associated with higher 
levels of depression. Better social support, family 
functioning, and physical health were associated 
with lower anxiety and depression (20).  
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Age   0.07‒0.27 0.18 0.001 
Gender  1.6‒2.2 1.9 0.349 
Education  0.3‒1.6 0.93 0.004 
Employment  0.7‒15.1 7.90 0.032 
Health in general 4.9‒10.2 7.60 <0.001 
Long-term illness 7.5‒24.5 16.1 <0.001 
Activity restriction 3.8‒8.9 6.40 <0.001 
Hypertension 0.5‒2.0 1.28 0.001 
Difficulties in performing daily activities 1.8‒4.5 3.17 <0.001 
Influence of the pain on activities perfor-
mance  
0.7‒2.5 1.59 <0.001 
The need for additional help with activities 2.3‒6.3 4.32 <0.001 
The need for help at home 1.8‒5.3 3.56 <0.001 
Presence of tension/stress 3.7‒5.9 4.80 <0.001 
Using daily hospital 0.05‒7.6 3.76 0.043 
Using home care 1.5‒9.4 5.46 0.008 
Using emergency help 5.6‒12.8 9.29 <0.001 
Unmet health care needs 0.5‒7.5 3.53 0.032 
Activity  0.6‒5.4 3.02 0.016 
Media 0.9‒6.7 3.84 0.011 
Social support 0.4‒3.6 2.03 0.015 
 
The studies examining levels of anxiety and de-
pression depending on the type of cancer, ac-
cording to the type of cancer revealed significant 
differences, so that patients with lung cancer, gy-
necological or hematological cancer reported the 
highest level of changes in mental health at the 
time of diagnosis (21, 22). Symptoms of depres-
sion and anxiety were more common in older 
patients than in younger ones, then in patients 
with lower education and rural areas, as well as in 
patients with a higher burden of symptoms and 
poorer physical functioning, while patients who 
were married were less likely to report anxiety 
symptoms and depression. It follows from all this 
that education can be a protective factor in the 
occurrence of depression and anxiety due to bet-
ter access to information about one's health con-
dition, understanding of treatment protocols. Al-
so, marital union, religiosity, and spirituality are 
recognized as a source of support that helps the 
oncology patient to overcome life difficulties and 
stressful events such as cancer diagnosis. The 
higher incidence of symptoms of depression and 
anxiety in patients in rural areas can be explained 
by the poor availability of health services faced by 
the rural population (23, 24). The data also show 
that in patients with a poorer prognosis, psycho-
logical distress increases significantly in the last 
two to three months before death, and especially 
in the last month of life (25, 26). In our research 
the level of depression and anxiety is higher in 
older subjects, in the presence of comorbidities, 
with greater limitations of activity, and the pres-
ence of difficulties in performing daily activities, 
with a more pronounced effect of pain on activi-
ty. 
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High levels of patient suffering and quality of life 
for cancer patients, especially those under stress 
and depression, should be an important public 
health issue. In that sense, it is necessary to ena-
ble adequate screening for depression and anxiety 
among patients with oncological diseases in order 
to prevent mental health disorders in this popula-
tion category. In addition, the gradual introduc-
tion of psycho-oncological interventions, such as 
counseling and psychotherapy, is a prerequisite 
for improving the quality of life of patients and a 




Identification of patients' psychosocial needs by 
health professionals, understanding of the pro-
cess of coping with the disease, and timely detec-
tion of mental health disorders are important 
steps in the reduction of mental disorders in pa-
tients with malignant diseases. Caring for the 
mental health of cancer patients must occupy a 
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